It is time for Jon Dudas to show true leadership
Well, it’s four days now since GlaxoSmithKline obtained its injunction preventing the USPTO’s new claims and continuations rules from coming into force. Not being a lawyer I have no idea whether the injunction will turn into something more permanent…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.